Supplemental material: histologic subtype of cutaneous immune-related adverse events predicts overall survival in patients receiving immune checkpoint inhibitors

Published: 29 November 2021| Version 1 | DOI: 10.17632/6cvsg3zvg4.1
Contributor:
Kelsey Hirotsu

Description

Supplemental tables/figures for the publication in JAAD, "Histologic subtype of cutaneous immune-related adverse events predicts overall survival in patients receiving immune checkpoint inhibitors". Accepted for publication 10/2021.

Files

Institutions

Stanford University

Categories

Dermatology, Immunotherapy, Histopathology, Supportive Care in Oncology

Licence